ChemicalBook >> journal list >> Aging-Us >>article
Aging-Us

Aging-Us

IF: 3.9
Download PDF

Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats

Published:29 July 2021 DOI: 10.18632/aging.203305 PMID: 34326272
Chang-Ning Fu, Hui Wei, Wen-Shuang Gao, Sha-Sha Song, Shou-Wei Yue, Yu-Juan Qu

Abstract

This study focused on the relationship between extracellular-regulated kinase (ERK) and obesity-induced increases in neuropathic pain. We fed rats a high-fat diet to establish the obesity model, and rats were given surgery to establish the chronic compression of the dorsal root ganglia (CCD) model. U0126 was applied to inhibit ERK, and metformin or 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) was applied to cause AMP-activated protein kinase (AMPK) activation. Paw withdrawal mechanical threshold (PWMT) were calculated to indicate the level of neuropathic pain. The data indicated that compared with normal CCD rats, the PWMT of obese CCD rats were decreased, accompanied with an increase of ERK phosphorylation, NAD(P)H oxidase 4 (NOX4) protein expression, oxidative stress and inflammatory level in the L4 to L5 spinal cord and dorsal root ganglia (DRG). Administration of U0126 could partially elevate the PWMT and reduce the protein expression of NOX4 and the above pathological changes in obese CCD rats. In vitro, ERK phosphorylation, NOX4 protein expression increased significantly in DRG neurons under the stimulation of palmitic acid (PA), accompanied with increased secretion of inflammatory factors, oxidative stress and apoptosis level, while U0126 partially attenuated the PA-induced upregulation of NOX4 and other pathological changes. In the rescue experiment, overexpression of NOX4 abolished the above protective effect of U0126 on DRG neurons in high-fat environment. Next, we explore upstream mechanisms. Metformin gavage significantly reduced neuropathic pain in obese CCD rats. For the mechanisms, activating AMPK with metformin (obese CCD rats) or AICAR (DRG neurons in a high-fat environment) not only inhibited the ERK-NOX4 pathway, but also improved oxidative stress and inflammation caused by high-fat. In conclusion, the AMPK-ERK-NOX4 pathway may has a pivotal role in mediating obesity-induced increases in neuropathic pain.

Substances (6)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Palmitic acid 57-10-3 C16H32O2 794 suppliers $5.00-$1166.55
Palmitic acid 57-10-3 C16H32O2 794 suppliers $5.00-$1166.55
Palmitic acid 57-10-3 C16H32O2 794 suppliers $5.00-$1166.55
Palmitic acid 57-10-3 C16H32O2 794 suppliers $5.00-$1166.55
Palmitic acid 57-10-3 C16H32O2 - Inquiry
Palmitic acid 57-10-3 C16H32O2 - Inquiry

Similar articles

IF:5.3

Sinomenine Ameliorated Microglial Activation and Neuropathic Pain After Chronic Constriction Injury Via TGF‐β1/ALK5/Smad3 Signalling Pathway

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE Ling Ling, Min Luo,etc Published: 25 November 2024
IF:6.1

RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway

Journal of Translational Medicine Huang, Zhidong,etc Published: 22 November 2024
IF:0

The anti-nociceptive effect of BPC-157 on the incisional pain model in rats

Journal of Dental Anesthesia and Pain Medicine Young-Hoon Jung, Haekyu Kim,etc Published: 25 March 2022